{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T13:58:18Z","timestamp":1790863098360,"version":"4.1.0"},"reference-count":113,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,12,15]],"date-time":"2020-12-15T00:00:00Z","timestamp":1607990400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI127387"],"award-info":[{"award-number":["AI127387"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>The immune response consists of a finely-tuned program, the activation of which must be coupled with inhibitory mechanisms whenever initiated. This ensures tight control of beneficial anti-pathogen and anti-tumor responses while preserving tissue integrity, promoting tissue repair, and safeguarding against autoimmunity. A cogent example of this binary response is in the mobilization of co-stimulatory and co-inhibitory signaling in regulating the strength and type of a T-cell response. Of particular importance is the costimulatory molecule CD28 which is countered by CTLA-4. While the role of CD28 in the immune response has been thoroughly elucidated, many aspects of CTLA-4 biology remain controversial. The expression of CD28 is largely constrained to constitutive expression in T-cells and as such, teasing out its function has been somewhat simplified by a limited and specific expression profile. The expression of CTLA-4, on the other hand, while reported predominantly in T-cells, has also been described on a diverse repertoire of cells within both lymphoid and myeloid lineages as well as on the surface of tumors. Nonetheless, the function of CTLA-4 has been mostly described within the context of T-cell biology. The focus on T-cell biology may be a direct result of the high degree of amino acid sequence homology and the co-expression pattern of CD28 and CTLA-4, which initially led to the discovery of CTLA-4 as a counter receptor to CD28 (for which a T-cell-activating role had already been described). Furthermore, observations of the outsized role of CTLA-4 in T<jats:sub>reg<\/jats:sub>-mediated immune suppression and the striking phenotype of T-cell hyperproliferation and resultant disease in CTLA-4<jats:sup>\u2212\/\u2212<\/jats:sup>mice contribute to an appropriate T-cell-centric focus in the study of CTLA-4. Complete elucidation of CTLA-4 biology, however, may require a more nuanced understanding of its role in a context other than that of T-cells. This makes particular sense in light of the remarkable, yet limited utility of anti-CTLA-4 antibodies in the treatment of cancers and of CTLA-4-Ig in autoimmune disorders like rheumatoid arthritis. By fully deducing the biology of CTLA-4-regulated immune homeostasis, bottlenecks that hinder the widespread applicability of CTLA-4-based immunotherapies can be resolved.<\/jats:p>","DOI":"10.3389\/fimmu.2020.608024","type":"journal-article","created":{"date-parts":[[2021,1,10]],"date-time":"2021-01-10T17:29:49Z","timestamp":1610299789000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":133,"title":["Beyond T-Cells: Functional Characterization of CTLA-4 Expression in Immune and Non-Immune Cell Types"],"prefix":"10.3389","volume":"11","author":[{"given":"Damilola","family":"Oyewole-Said","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanaja","family":"Konduri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Vazquez-Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott A.","family":"Weldon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan M.","family":"Levitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William K.","family":"Decker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,12,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/328267a0","article-title":"A new member of the immunoglobulin superfamily\u2013CTLA-4","volume":"328","author":"Brunet","year":"1987","journal-title":"Nature"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/366076a0","article-title":"B70 antigen is a second ligand for CTLA-4 and CD28","volume":"366","author":"Azuma","year":"1993","journal-title":"Nature"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1084\/jem.174.3.561","article-title":"CTLA-4 is a second receptor for the B cell activation antigen B7","volume":"174","author":"Linsley","year":"1991","journal-title":"J Exp Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1084\/jem.173.3.721","article-title":"Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation","volume":"173","author":"Linsley","year":"1991","journal-title":"J Exp Med"},{"key":"B5","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.144.5.1646","article-title":"CD28 is an inducible T cell surface antigen that transduces a proliferative signal in CD3+ mature thymocytes","volume":"144","author":"Turka","year":"1990","journal-title":"J Immunol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.168.9.4420","article-title":"CTLA-4 suppresses proximal TCR signaling in resting human CD4(+) T cells by inhibiting ZAP-70 Tyr(319) phosphorylation: a potential role for tyrosine phosphatases","volume":"168","author":"Guntermann","year":"2002","journal-title":"J Immunol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2866","article-title":"Protein kinase C-eta controls CTLA-4-mediated regulatory T cell function","volume":"15","author":"Kong","year":"2014","journal-title":"Nat Immunol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20141030","article-title":"Deletion of CTLA-4 on regulatory T cells during adulthood leads to resistance to autoimmunity","volume":"212","author":"Paterson","year":"2015","journal-title":"J Exp Med"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2004.06.017","article-title":"B7-1 and B7-2 selectively recruit CTLA-4 and CD28 to the immunological synapse","volume":"21","author":"Pentcheva-Hoang","year":"2004","journal-title":"Immunity"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M111.304329","article-title":"Constitutive clathrin-mediated endocytosis of CTLA-4 persists during T cell activation","volume":"287","author":"Qureshi","year":"2012","journal-title":"J Biol Chem"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1401876","article-title":"A transendocytosis model of CTLA-4 function predicts its suppressive behavior on regulatory T cells","volume":"194","author":"Hou","year":"2015","journal-title":"J Immunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1084\/jem.182.2.459","article-title":"CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation","volume":"182","author":"Krummel","year":"1995","journal-title":"J Exp Med"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.humimm.2013.05.012","article-title":"Kinetics of the CTLA-4 isoforms expression after T-lymphocyte activation and role of the promoter polymorphisms on CTLA-4 gene transcription","volume":"74","author":"Perez-Garcia","year":"2013","journal-title":"Hum Immunol"},{"key":"B14","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.156.11.4154","article-title":"Regulation of CTLA-4 expression during T cell activation","volume":"156","author":"Perkins","year":"1996","journal-title":"J Immunol"},{"key":"B15","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.151.7.3489","article-title":"Characterization of CTLA-4 structure and expression on human T cells","volume":"151","author":"Lindsten","year":"1993","journal-title":"J Immunol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1126\/science.1160062","article-title":"CTLA-4 control over Foxp3+ regulatory T cell function","volume":"322","author":"Wing","year":"2008","journal-title":"Science"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1084\/jem.192.2.303","article-title":"Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4","volume":"192","author":"Takahashi","year":"2000","journal-title":"J Exp Med"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.177.7.4376","article-title":"Blockade of CTLA-4 on CD4+CD25+ regulatory T cells abrogates their function in vivo","volume":"177","author":"Read","year":"2006","journal-title":"J Immunol"},{"key":"B19","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.159.1.144","article-title":"Interaction of CTLA-4 with the clathrin-associated protein AP50 results in ligand-independent endocytosis that limits cell surface expression","volume":"159","author":"Chuang","year":"1997","journal-title":"J Immunol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(00)80346-5","article-title":"Tyrosine phosphorylation controls internalization of CTLA-4 by regulating its interaction with clathrin-associated adaptor complex AP-2","volume":"6","author":"Shiratori","year":"1997","journal-title":"Immunity"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.01331-13","article-title":"Rab8 binding to immune cell-specific adaptor LAX facilitates formation of trans-Golgi network-proximal CTLA-4 vesicles for surface expression","volume":"34","author":"Banton","year":"2014","journal-title":"Mol Cell Biol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1126\/science.1202947","article-title":"Trans-endocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4","volume":"332","author":"Qureshi","year":"2011","journal-title":"Science"},{"key":"B23","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/j.1600-065X.2009.00770.x","article-title":"CD28 and CTLA-4 coreceptor expression and signal transduction","volume":"229","author":"Rudd","year":"2009","journal-title":"Immunol Rev"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1021\/bi971762i","article-title":"Interaction of the cytoplasmic tail of CTLA-4 (CD152) with a clathrin-associated protein is negatively regulated by tyrosine phosphorylation","volume":"36","author":"Bradshaw","year":"1997","journal-title":"Biochemistry"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.165.9.5062","article-title":"Regulation of cell surface expression of CTLA-4 by secretion of CTLA-4-containing lysosomes upon activation of CD4+ T cells","volume":"165","author":"Iida","year":"2000","journal-title":"J Immunol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaa1663","article-title":"AUTOIMMUNE DISEASE. Patients with LRBA deficiency show CTLA4 loss and immune dysregulation responsive to abatacept therapy","volume":"349","author":"Lo","year":"2015","journal-title":"Science"},{"key":"B27","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s10875-015-0224-7","article-title":"Spectrum of Phenotypes Associated with Mutations in LRBA","volume":"36","author":"Alkhairy","year":"2016","journal-title":"J Clin Immunol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1016\/j.jaci.2017.05.022","article-title":"Exaggerated follicular helper T-cell responses in patients with LRBA deficiency caused by failure of CTLA4-mediated regulation","volume":"141","author":"Alroqi","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2014.10.019","article-title":"Regulatory T-cell deficiency and immune dysregulation, polyendocrinopathy, enteropathy, X-linked-like disorder caused by loss-of-function mutations in LRBA","volume":"135","author":"Charbonnier","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2015.09.025","article-title":"The extended phenotype of LPS-responsive beige-like anchor protein (LRBA) deficiency","volume":"137","author":"Gamez-Diaz","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/j.ajhg.2012.04.015","article-title":"Deleterious mutations in LRBA are associated with a syndrome of immune deficiency and autoimmunity","volume":"90","author":"Lopez-Herrera","year":"2012","journal-title":"Am J Hum Genet"},{"key":"B32","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/S1074-7613(94)80021-9","article-title":"Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors","volume":"1","author":"Linsley","year":"1994","journal-title":"Immunity"},{"key":"B33","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1084\/jem.185.3.393","article-title":"CD80 (B7-1) binds both CD28 and CTLA-4 with a low affinity and very fast kinetics","volume":"185","author":"van der Merwe","year":"1997","journal-title":"J Exp Med"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2010.09.006","article-title":"Spatiotemporal basis of CTLA-4 costimulatory molecule-mediated negative regulation of T cell activation","volume":"33","author":"Yokosuka","year":"2010","journal-title":"Immunity"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0706509104","article-title":"Induction of autoimmune disease in CTLA-4-\/- mice depends on a specific CD28 motif that is required for in vivo costimulation","volume":"104","author":"Tai","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1084\/jem.181.1.351","article-title":"CTLA-4 binding to the lipid kinase phosphatidylinositol 3-kinase in T cells","volume":"181","author":"Schneider","year":"1995","journal-title":"J Exp Med"},{"key":"B37","doi-asserted-by":"publisher","first-page":"e31391","DOI":"10.1371\/journal.pone.0031391","article-title":"Migration of Th1 lymphocytes is regulated by CD152 (CTLA-4)-mediated signaling via PI3 kinase-dependent Akt activation","volume":"7","author":"Knieke","year":"2012","journal-title":"PloS One"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1126\/science.272.5265.1170","article-title":"Regulation of T cell receptor signaling by tyrosine phosphatase SYP association with CTLA-4","volume":"272","author":"Marengere","year":"1996","journal-title":"Science"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1126\/science.282.5397.2263","article-title":"Molecular basis of T cell inactivation by CTLA-4","volume":"282","author":"Lee","year":"1998","journal-title":"Science"},{"key":"B40","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/1471-2172-10-23","article-title":"Structure-Function analysis of the CTLA-4 interaction with PP2A","volume":"10","author":"Teft","year":"2009","journal-title":"BMC Immunol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.168.10.5070","article-title":"Inhibition of CTLA-4 function by the regulatory subunit of serine\/threonine phosphatase 2A","volume":"168","author":"Baroja","year":"2002","journal-title":"J Immunol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20031058","article-title":"CD152 (CTLA-4) determines the unequal resistance of Th1 and Th2 cells against activation-induced cell death by a mechanism requiring PI3 kinase function","volume":"199","author":"Pandiyan","year":"2004","journal-title":"J Exp Med"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1126\/science.1131078","article-title":"Reversal of the TCR stop signal by CTLA-4","volume":"313","author":"Schneider","year":"2006","journal-title":"Science"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1126\/science.270.5238.985","article-title":"Lymphoproliferative disorders with early lethality in mice deficient in\u00a0Ctla-4","volume":"270","author":"Waterhouse","year":"1995","journal-title":"Science"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1128\/CDLI.12.6.705-712.2005","article-title":"Inhibitory receptors CD85j, LAIR-1, and CD152 down-regulate immunoglobulin and cytokine production by human B lymphocytes","volume":"12","author":"Merlo","year":"2005","journal-title":"Clin Diagn Lab Immunol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.165.10.5530","article-title":"Inhibition of IgG1 and IgE production by stimulation of the B cell CTLA-4 receptor","volume":"165","author":"Pioli","year":"2000","journal-title":"J Immunol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-06-1668","article-title":"CTLA-4 is not restricted to the lymphoid cell lineage and can function as a target molecule for apoptosis induction of leukemic cells","volume":"101","author":"Pistillo","year":"2003","journal-title":"Blood"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.179.11.7316","article-title":"A new role of CTLA-4 on B cells in thymus-dependent immune responses in vivo","volume":"179","author":"Quandt","year":"2007","journal-title":"J Immunol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2014.12.005","article-title":"The coinhibitory receptor CTLA-4 controls B cell responses by modulating T follicular helper, T follicular regulatory, and T regulatory cells","volume":"41","author":"Sage","year":"2014","journal-title":"Immunity"},{"key":"B50","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.155.4.1776","article-title":"Activated T cells can induce high levels of CTLA-4 expression on B cells","volume":"155","author":"Kuiper","year":"1995","journal-title":"J Immunol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/imm.12171","article-title":"Identification of co-expressed gene signatures in mouse B1, marginal zone and B2 B-cell populations","volume":"141","author":"Mabbott","year":"2014","journal-title":"Immunology"},{"key":"B52","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/icb.2017.52","article-title":"Immunological phenotype of the murine Lrba knockout","volume":"95","author":"Gamez-Diaz","year":"2017","journal-title":"Immunol Cell Biol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1302091","article-title":"CTLA-4 is expressed by activated mouse NK cells and inhibits NK Cell IFN-gamma production in response to mature dendritic cells","volume":"192","author":"Stojanovic","year":"2014","journal-title":"J Immunol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2018.06.010","article-title":"CTLA-4 regulates human Natural Killer cell effector functions","volume":"194","author":"Lougaris","year":"2018","journal-title":"Clin Immunol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s12967-015-0479-z","article-title":"Favorable in vitro effects of combined IL-12 and IL-18 treatment on NK cell cytotoxicity and CD25 receptor expression in metastatic melanoma patients","volume":"13","author":"Mirjacic Martinovic","year":"2015","journal-title":"J Transl Med"},{"key":"B56","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.162.8.4511","article-title":"Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: implications for the innate immune response","volume":"162","author":"Fehniger","year":"1999","journal-title":"J Immunol"},{"key":"B57","doi-asserted-by":"crossref","first-page":"62","DOI":"10.4049\/jimmunol.163.1.62","article-title":"Expression of a variant of CD28 on a subpopulation of human NK cells: implications for B7-mediated stimulation of NK cells","volume":"163","author":"Galea-Lauri","year":"1999","journal-title":"J Immunol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1111\/j.0019-2805.2004.01834.x","article-title":"CD28 is not directly involved in the response of human CD3- CD56+ natural killer cells to lipopolysaccharide: a role for T cells","volume":"111","author":"Goodier","year":"2004","journal-title":"Immunology"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1186\/ar567","article-title":"The instructive role of dendritic cells on T-cell responses","author":"Sallusto","year":"2002","journal-title":"Arthritis Res"},{"key":"B60","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/S1074-7613(00)80461-6","article-title":"The duration of antigenic stimulation determines the fate of naive and effector T cells","volume":"8","author":"Iezzi","year":"1998","journal-title":"Immunity"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1038\/32588","article-title":"Dendritic cells and the control of immunity","volume":"392","author":"Banchereau","year":"1998","journal-title":"Nature"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26694","article-title":"Human CD14+ CTLA-4+ regulatory dendritic cells suppress T-cell response by cytotoxic T-lymphocyte antigen-4-dependent IL-10 and indoleamine-2,3-dioxygenase production in hepatocellular carcinoma","volume":"59","author":"Han","year":"2014","journal-title":"Hepatology"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1016\/j.humimm.2010.07.007","article-title":"CTLA-4 is expressed by human monocyte-derived dendritic cells and regulates their functions","volume":"71","author":"Laurent","year":"2010","journal-title":"Hum Immunol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1046\/j.0300-9475.2001.01019.x","article-title":"Expression of CTLA-4 by human monocytes","volume":"55","author":"Wang","year":"2002","journal-title":"Scand J Immunol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1089\/scd.2016.0009","article-title":"Dendritic Cell-Secreted Cytotoxic T-Lymphocyte-Associated Protein-4 Regulates the T-cell Response by Downmodulating Bystander Surface B7","volume":"25","author":"Halpert","year":"2016","journal-title":"Stem Cells Dev"},{"key":"B66","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1471-2172-12-21","article-title":"CTLA4 is expressed on mature dendritic cells derived from human monocytes and influences their maturation and antigen presentation","volume":"12","author":"Wang","year":"2011","journal-title":"BMC Immunol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1096\/fj.201903002R","article-title":"and II peptide homology regulates the cellular immune response","volume":"34","author":"Halpert","year":"2020","journal-title":"FASEB J"},{"key":"B68","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.jim.2015.08.015","article-title":"Flow cytometric gating for spleen monocyte and DC subsets: differences in autoimmune NOD mice and with acute inflammation","volume":"432","author":"Dong","year":"2016","journal-title":"J Immunol Methods"},{"key":"B69","doi-asserted-by":"publisher","first-page":"e1151594","DOI":"10.1080\/2162402X.2016.1151594","article-title":"CTLA4 blockade reduces immature myeloid cells in head and neck squamous cell carcinoma","volume":"5","author":"Yu","year":"2016","journal-title":"Oncoimmunology"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9896(199710)183:2<182::AID-PATH918>3.0.CO;2-I","article-title":"In vivo expression of the CTLA4 inhibitory receptor in malignant and reactive cells from human lymphomas","volume":"183","author":"Xerri","year":"1997","journal-title":"J Pathol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-2478(99)00081-4","article-title":"Activation of lymphocytes by BAT and anti CTLA-4: comparison of binding to T and B cells","volume":"69","author":"Raiter","year":"1999","journal-title":"Immunol Lett"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1002\/1521-4141(200202)32:2<366::AID-IMMU366>3.0.CO;2-5","article-title":"CTLA-4 regulates cell cycle progression during a primary immune response","volume":"32","author":"Greenwald","year":"2002","journal-title":"Eur J Immunol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1002\/1521-4141(200202)32:2<366::AID-IMMU366>3.0.CO;2-5","article-title":"CTLA-4-Mediated inhibition of early events of T cell proliferation","volume":"162","author":"Brunner","year":"1999","journal-title":"J Immunol"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403588","article-title":"CTLA-4 overexpression in CD19+\/CD5+ cells correlates with the level of cell cycle regulators and disease progression in B-CLL patients","volume":"19","author":"Kosmaczewska","year":"2005","journal-title":"Leukemia"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1801359","article-title":"Leukemic B Cell CTLA-4 Suppresses Costimulation of T Cells","volume":"202","author":"Do","year":"2019","journal-title":"J Immunol"},{"key":"B76","doi-asserted-by":"publisher","first-page":"e70352","DOI":"10.1371\/journal.pone.0070352","article-title":"Role of CTLA4 in the proliferation and survival of chronic lymphocytic leukemia","volume":"8","author":"Mittal","year":"2013","journal-title":"PloS One"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-07-0283","article-title":"ATM, CTLA4, MNDA, and HEM1 in high versus low CD38 expressing B-cell chronic lymphocytic leukemia","volume":"13","author":"Joshi","year":"2007","journal-title":"Clin Cancer Res"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-015-1696-2","article-title":"Cytotoxic T lymphocyte antigen 4 expression in human breast cancer: implications for prognosis","volume":"64","author":"Yu","year":"2015","journal-title":"Cancer Immunol Immunother"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.14626","article-title":"CTLA-4 positive breast cancer cells suppress dendritic cells maturation and function","volume":"8","author":"Chen","year":"2017","journal-title":"Oncotarget"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.24645","article-title":"High CTLA-4 expression correlates with poor prognosis in thymoma patients","volume":"9","author":"Santoni","year":"2018","journal-title":"Oncotarget"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.8476","article-title":"Cytotoxic T lymphocyte antigen-4 expression in esophageal carcinoma: implications for prognosis","volume":"7","author":"Zhang","year":"2016","journal-title":"Oncotarget"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.7421","article-title":"Tumor CTLA-4 overexpression predicts poor survival in patients with nasopharyngeal carcinoma","volume":"7","author":"Huang","year":"2016","journal-title":"Oncotarget"},{"key":"B83","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.3390\/cancers11101535","article-title":"Detailed Characterization of Immune Cell Infiltrate and Expression of Immune Checkpoint Molecules PD-L1\/CTLA-4 and MMR Proteins in Testicular Germ Cell Tumors Disclose Novel Disease Biomarkers","volume":"11","author":"Lobo","year":"2019","journal-title":"Cancers (Basel)"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-012-1211-y","article-title":"Evaluation of CTLA-4 expression and relevance as a novel prognostic factor in patients with non-small cell lung cancer","volume":"61","author":"Salvi","year":"2012","journal-title":"Cancer Immunol Immunother"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1007\/s11523-016-0474-1","article-title":"Clinical Implications of Cytotoxic T Lymphocyte Antigen-4 Expression on Tumor Cells and Tumor-Infiltrating Lymphocytes in Extrahepatic Bile Duct Cancer Patients Undergoing Surgery Plus Adjuvant Chemoradiotherapy","volume":"12","author":"Lim","year":"2017","journal-title":"Target Oncol"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-017-2039-2","article-title":"CTLA-4 expression in the non-small cell lung cancer patient tumor microenvironment: diverging prognostic impact in primary tumors and lymph node metastases","volume":"66","author":"Paulsen","year":"2017","journal-title":"Cancer Immunol Immunother"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-17-1615","article-title":"Interferon-gamma Signaling in Melanocytes and Melanoma Cells Regulates Expression of CTLA-4","volume":"78","author":"Mo","year":"2018","journal-title":"Cancer Res"},{"key":"B88","doi-asserted-by":"publisher","first-page":"108428","DOI":"10.1016\/j.clim.2020.108428","article-title":"Phenotypic characterization of tumor CTLA-4 expression in melanoma tissues and its possible role in clinical response to Ipilimumab","volume":"215","author":"Pistillo","year":"2020","journal-title":"Clin Immunol"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2018.9354","article-title":"Potential function of CTLA-4 in the tumourigenic capacity of melanoma stem cells","volume":"16","author":"Zhang","year":"2018","journal-title":"Oncol Lett"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1038\/cmi.2015.11","article-title":"Short-term memory of danger signals or environmental stimuli in mesenchymal stem cells: implications for therapeutic potential","volume":"13","author":"Liu","year":"2016","journal-title":"Cell Mol Immunol"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1634\/stemcells.2007-0454","article-title":"Toll-like receptors 3 and 4 are expressed by human bone marrow-derived mesenchymal stem cells and can inhibit their T-cell modulatory activity by impairing Notch signaling","volume":"26","author":"Liotta","year":"2008","journal-title":"Stem Cells"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1556\/1886.2017.00009","article-title":"Fibroblasts: The Unknown Sentinels Eliciting Immune Responses Against Microorganisms","volume":"7","author":"Bautista-Hernandez","year":"2017","journal-title":"Eur J Microbiol Immunol (Bp)"},{"key":"B93","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.160.3.1053","article-title":"CD40 engagement up-regulates cyclooxygenase-2 expression and prostaglandin E2 production in human lung fibroblasts","volume":"160","author":"Zhang","year":"1998","journal-title":"J Immunol"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1038\/ni1130","article-title":"Splenic stroma drives mature dendritic cells to differentiate into regulatory dendritic cells","volume":"5","author":"Zhang","year":"2004","journal-title":"Nat Immunol"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kel065","article-title":"Synovial fibroblasts: key players in rheumatoid arthritis","volume":"45","author":"Huber","year":"2006","journal-title":"Rheumatol (Oxford)"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/5.7.1075","article-title":"The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Belgian Diabetes Registry","volume":"5","author":"Nistico","year":"1996","journal-title":"Hum Mol Genet"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2020.00481","article-title":"Genetic Association Study of IL2RA, IFIH1, and CTLA-4 Polymorphisms With Autoimmune Thyroid Diseases and Type 1 Diabetes","volume":"8","author":"Borysewicz-Sanczyk","year":"2020","journal-title":"Front Pediatr"},{"key":"B98","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/s12020-019-01859-3","article-title":"Association and gene-gene interaction analyses for polymorphic variants in CTLA-4 and FOXP3 genes: role in susceptibility to autoimmune thyroid disease","volume":"64","author":"Fathima","year":"2019","journal-title":"Endocrine"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1089\/gtmb.2012.0302","article-title":"CTLA-4 polymorphisms and systemic lupus erythematosus: a comprehensive meta-analysis","volume":"17","author":"Liu","year":"2013","journal-title":"Genet Test Mol Biomarkers"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200939781","article-title":"Abnormal CTLA-4 function in T cells from patients with systemic lupus erythematosus","volume":"40","author":"Jury","year":"2010","journal-title":"Eur J Immunol"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ejhg.5201357","article-title":"A common CTLA4 haplotype associated with coeliac disease","volume":"13","author":"Hunt","year":"2005","journal-title":"Eur J Hum Genet"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1093\/molehr\/5.1.84","article-title":"The CTLA-4 gene is expressed in placental fibroblasts","volume":"5","author":"Kaufman","year":"1999","journal-title":"Mol Hum Reprod"},{"key":"B103","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.3390\/ijms19082312","article-title":"CTLA-4 Mediates Inhibitory Function of Mesenchymal Stem\/Stromal Cells","volume":"19","author":"Gaber","year":"2018","journal-title":"Int J Mol Sci"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1006\/clim.1999.4743","article-title":"Costimulatory markers in muscle of patients with idiopathic inflammatory myopathies and in cultured muscle cells","volume":"92","author":"Nagaraju","year":"1999","journal-title":"Clin Immunol"},{"key":"B105","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/scrt2","article-title":"Immunosuppression by mesenchymal stem cells: mechanisms and clinical applications","volume":"1","author":"Ghannam","year":"2010","journal-title":"Stem Cell Res Ther"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.00682","article-title":"Papillomavirus Immune Evasion Strategies Target the Infected Cell and the Local Immune System","volume":"9","author":"Zhou","year":"2019","journal-title":"Front Oncol"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/8.6.850","article-title":"Immunosuppression in viral infections","volume":"8","author":"Rouse","year":"1986","journal-title":"Rev Infect Dis"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2019.10.001","article-title":"Induction of co-inhibitory molecule CTLA-4 by human papillomavirus E7 protein through downregulation of histone methyltransferase JHDM1B expression","volume":"538","author":"Zhou","year":"2019","journal-title":"Virology"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1016\/1074-7613(95)90125-6","article-title":"Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4","volume":"3","author":"Tivol","year":"1995","journal-title":"Immunity"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1172\/JCI11710","article-title":"B7-dependent T-cell costimulation in mice lacking CD28 and CTLA4","volume":"107","author":"Mandelbrot","year":"2001","journal-title":"J Clin Invest"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.164.10.5319","article-title":"Structural analysis of CTLA-4 function in vivo","volume":"164","author":"Masteller","year":"2000","journal-title":"J Immunol"},{"key":"B112","doi-asserted-by":"publisher","first-page":"e0195958","DOI":"10.1371\/journal.pone.0195958","article-title":"Expression of immune checkpoint regulators, cytotoxic T lymphocyte antigen 4 (CTLA-4) and programmed death-ligand 1 (PD-L1), in female breast carcinomas","volume":"13","author":"Kassardjian","year":"2018","journal-title":"PloS One"},{"key":"B113","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/1479-5876-11-108","article-title":"The engagement of CTLA-4 on primary melanoma cell lines induces antibody-dependent cellular cytotoxicity and TNF-alpha production","volume":"11","author":"Laurent","year":"2013","journal-title":"J Transl Med"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2020.608024\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T09:13:23Z","timestamp":1697534003000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2020.608024\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,15]]},"references-count":113,"alternative-id":["10.3389\/fimmu.2020.608024"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.608024","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,15]]},"article-number":"608024"}}